Article info
PDFPostScript
Letter
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK
- Correspondence to Dr Karen O'Connell, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, Oxfordshire OX3 9DU, UK; kazzoc{at}hotmail.com
Citation
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK
Publication history
- Received March 4, 2020
- Revised May 19, 2020
- Accepted May 21, 2020
- First published June 23, 2020.
Online issue publication
September 15, 2020
Article Versions
- Previous version (23 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.